|
ICH Seeks Benefit Highlights in Drugmaker Risk-Benefit Reports
A new International Conference on Harmonisation (ICH) report seeks streamlined postmarket safety filings for drugmakers while adding a new feature to highlight products’ benefits.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives